Early Access — free while we kick the tires
EdgarHawk

Aikawa Yoshiyuki

Chairman and CEO

Director Officer 10% Owner

Latest: Chair selling · April 2026

2 filings analyzed · 1 company · Latest 2026-04-29

Companies

Company Buys Sells Direction
SBC Medical Group Holdings Inc SBC 0 2 Net selling

Activity

April 2026
medium
Sell
465,000 shares
$1,405,462
Significance 4/10

Chairman/CEO Aikawa Yoshiyuki sold 465,000 shares of SBC at $3.02 on 2026-04-28; stock down -41.6% from 52-week high.

Aikawa Yoshiyuki sold 465,000 shares for $1,405,462.50, reducing holdings from 79,304,460 to 78,839,460 shares (a -0.6% reduction in his position). The transaction occurred at $3.02 per share, while the stock currently trades at $3.30, having declined -19.3% over the past 30 days and -22.0% over 90 days from a 52-week high of $5.65. This is the second open-market sale by Aikawa at SBC within 8 days (following an April 21 sale), suggesting a pattern of sustained liquidation during a period of significant stock weakness. While his cross-ticker track record across all open-market history shows an average 30-day return of +110.8% following prior sales, his same-ticker history at SBC shows a single measurable outcome of +110.8% 30-day return after the March 6 sale, providing limited evidence of timing accuracy at this specific ticker. The company's fundamentals show revenue of $43,353,235.00 and net income of $12,824,636.00 in the latest quarter, but annual revenue has contracted -15.5% year-over-year, and the stock is trading well below recent highs despite a relatively low P/E of 7.17.

medium
Sell
3,100,000 shares
$9,369,750
Significance 4/10

Aikawa Yoshiyuki (Chairman and CEO) sells 3,100,000 shares of SBC at $3.02 for $9,369,750.00 on 2026-04-21

Chairman and CEO Aikawa Yoshiyuki sold 3,100,000 shares at $3.02 per share on April 21, 2026, reducing his holdings from 82,404,460 to 79,304,460 shares. The stock has declined -39.8% from its 52-week high of $5.65 and is trading at $3.40 currently, down -11.9% over the past 30 days and -22.2% over 90 days, indicating significant recent weakness. SBC's fundamentals show concerning trends: annual revenue contracted -15.5% year-over-year despite a low P/E of 7.39, and this represents the CEO's only prior trade at this ticker, providing limited historical context for evaluating pattern significance relative to his cross-ticker track record of average 30-day returns of +110.8%.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access